Last Update: Jun 04, 2026 A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Adult Participants With Prostate Cancer ClinicalTrials.gov Identifier: [NCT05803941](https://clinicaltrials.gov/ct2/show/NCT05803941) Novartis Reference Number:CAAA617A12402 [See if you Pre-qualify](#trial-eligibility "See if you Pre-qualify") All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the use(s) under investigation. ## Study Description The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as \\\[177Lu\\\]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617. The study also seeks to further characterize (as possible) any other AAA617 causally related serious adverse event(s) in the long-term in adults with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials. This is a global, prospective, multi-center, long-term follow-up (LTFU) safety study of adult participants with prostate cancer that have received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials. There will be no study treatment administered to participants in this study. Participants will have visits every 6-8 months for monitoring of selected AEs and laboratory parameters. The study periods include a Baseline and Follow-up Period (up to 10 years after first dose of AAA617 in parent treatment study). Participants should enroll into the LTFU study after parent treatment study requirements are fulfilled (refer to the parent treatment study protocol for requirements, including any additional requirements after participant enters this LTFU safety study). The schedule of activities for this LTFU study is designed to start from date of informed consent for this LTFU study. Participants should be followed every 6 to 8 months for up to a total of 10 years starting from first dose of AAA617 in the parent treatment study. Participants entering the LTFU study will have already completed a variable portion of the required 10-year follow-up within the parent treatment study. The specific number of visits required in this LTFU study will depend upon the time of enrollment into this LTFU study following the first dose of AAA617 in the parent treatment study. The total number of participants to be enrolled and the duration of this LTFU study will depend upon the total number treated in the parent treatment studies and their duration. Condition Prostate Cancer Phase Phase4 Overall Status Recruiting Number of Participants700 Start Date Aug 14, 2023 Completion Date Jul 21, 2033 Gender Male Age(s) 18 Years - 100 Years (Adult, Older Adult) ## Interventions Drug ### AAA617 Long-term follow-up (LTFU) safety study of adult participants with prostate cancer that have received at least one dose of AAA617 from parent interventional Novartis sponsored clinical trials. ## Eligibility Criteria Inclusion Criteria: \* Signed informed consent must be obtained prior to participation in the study \* Must have received at least one dose of AAA617 within an interventional, Phase I-IV Novartis sponsored clinical trial in prostate cancer and have fulfilled the trial's requirements that allows them to participate in this study. Exclusion Criteria: \\- Inability to complete the needed investigational examinations due to any reason. Austria #### Novartis Investigative Site Recruiting Vienna,1090,Austria #### Novartis Investigative Site Recruiting Linz,4020,Austria Belgium #### Novartis Investigative Site Recruiting Ghent,9000,Belgium Canada #### Novartis Investigative Site Recruiting Montreal,Quebec,H2x 1r9,Canada Czechia #### Novartis Investigative Site Recruiting Olomouc,779 00,Czechia #### Novartis Investigative Site Recruiting Prague,150 06,Czechia France #### Novartis Investigative Site Recruiting Lyon,69373,France Germany #### Novartis Investigative Site Recruiting Rostock,18057,Germany #### Novartis Investigative Site Recruiting Essen,45147,Germany #### Novartis Investigative Site Recruiting München,80377,Germany Netherlands #### Novartis Investigative Site Recruiting Delft,South Holland,2625 ad,Netherlands #### Novartis Investigative Site Recruiting Maastricht,Limburg,6229 hx,Netherlands #### Novartis Investigative Site Recruiting Nijmegen,Gelderland,6500hb,Netherlands Spain #### Novartis Investigative Site Recruiting Madrid,28040,Spain #### Novartis Investigative Site Recruiting Barcelona,08036,Spain #### Novartis Investigative Site Recruiting Madrid,28041,Spain #### Novartis Investigative Site Recruiting Madrid,28046,Spain #### Novartis Investigative Site Recruiting Valencia,46026,Spain #### Novartis Investigative Site Recruiting Sabadell,Barcelona,08208,Spain #### Novartis Investigative Site Recruiting Barcelona,08035,Spain #### Novartis Investigative Site Recruiting Majadahonda,Madrid,28222,Spain #### Novartis Investigative Site Recruiting L'Hospitalet de Llobregat,Barcelona,08907,Spain #### Novartis Investigative Site Recruiting Madrid,28034,Spain Sweden #### Novartis Investigative Site Recruiting Stockholm,17176,Sweden #### Novartis Investigative Site Recruiting Gothenburg,413 45,Sweden United Kingdom #### Novartis Investigative Site Recruiting Barnet,En5 3dj,United Kingdom #### Novartis Investigative Site Recruiting Cambridge,Cb2 0qq,United Kingdom #### Novartis Investigative Site Recruiting Glasgow,G12 0yn,United Kingdom #### Novartis Investigative Site Recruiting Middlesbrough,Ts4 3bw,United Kingdom #### Novartis Investigative Site Recruiting Sutton,Surrey,Sm2 5pt,United Kingdom United States #### Onco Hemato Asso of SW Virginia Recruiting Roanoke,Virginia,24014,United States Phone: [540-774-8660](tel:540-774-8660) ###### David Buck #### Montefiore Medical Center Recruiting The Bronx,New York,10467,United States ###### Benjamin A Gartrell #### Wash U School of Medicine Recruiting St Louis,Missouri,63110,United States ###### Lindsey Mayer Email: ###### Hyun Kim #### VA Medical Center Recruiting Washington D.C.,District of Columbia,20422,United States ###### Frank Liu Phone: [202-745-8457](tel:202-745-8457) #### Hartford Hospital Recruiting Hartford,Connecticut,06102,United States ###### Andrew Salner #### UT Health Science Center Recruiting Houston,Texas,77030,United States ###### Bo Chen #### Univ of Texas Southwest Med Center Recruiting Dallas,Texas,75390-9034,United States ###### Kevin Courtney #### Univ of Pittsburgh Medical Center Recruiting Pittsburgh,Pennsylvania,15232,United States ###### Leonard Appleman #### St. Joseph Hospital Recruiting Orange,California,92686,United States ###### Timothy Byun #### Mayo Clinic Arizona Recruiting Scottsdale,Arizona,85259,United States ###### Cassandra Moore Phone: [480-301-8300](tel:480-301-8300) #### Tulane Cancer Center Recruiting New Orleans,Louisiana,70112,United States Phone: [504-585-6077](tel:504-585-6077) ###### Brian Lewis #### Ochsner Clinic Foundation Recruiting New Orleans,Louisiana,70121,United States Phone: [504-842-6044](tel:504-842-6044) ###### Stephen Bardot #### University of Mississippi Med Ctr Recruiting Jackson,Mississippi,39216,United States Phone: [+1 601 815 5374]() ###### John Clark Henegan #### Urology Cancer Center PC Recruiting Omaha,Nebraska,68130,United States Phone: [402-697-2229](tel:402-697-2229) ###### Luke Nordquist #### Cleveland Clinic Foundation Recruiting Cleveland,Ohio,44195,United States Phone: [216-444-0441](tel:216-444-0441) ###### Shilpa Gupta #### Duke University Medical Center Recruiting Durham,North Carolina,27710,United States ###### Daniel J George #### Providence Saint Johns Health Ctr Recruiting Santa Monica,California,90404,United States ###### Przemyslaw Twardowski #### University of Colorado Recruiting Aurora,Colorado,80045,United States ###### Muthiah Nachiappan #### Mayo Clinic Jacksonville Recruiting Jacksonville,Florida,32224,United States ###### Winston Tan #### University Cancer and Blood Center LLC Recruiting Athens,Georgia,30607,United States Phone: [706-353-2990](tel:706-353-2990) ###### Petros Nikolinakos #### Parkview Research Center Recruiting Fort Wayne,Indiana,46845,United States ###### Brian Chang #### Corewell Health William Beaum Hosp Recruiting Royal Oak,Michigan,48073-6769,United States ###### Andrew Thompson #### Mayo Clinic Rochester Recruiting Rochester,Minnesota,55905,United States ###### Brian Costello #### Nebraska Cancer Specialists Recruiting Omaha,Nebraska,68154,United States ###### Ralph Hauke ## Worldwide Contacts If the location of your choosing does not feature any contact detail, please reach out using the information below. #### Novartis Pharmaceuticals Phone: [ +41613241111](tel:+41613241111) Email: #### Novartis Pharmaceuticals Phone: [ 1-888-669-6682](tel:1-888-669-6682) Email: